Formula (I) Antiviral Compounds for Multi-Virus Replication Inhibition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a pressing need for effective treatments or cures for coronavirus, picornavirus, and norovirus infections, as current treatments are lacking, particularly for COVID-19 caused by SARS-CoV-2, which is highly contagious and has no specific antiviral treatment.
Innovation Solution
Development of compounds of Formula (I) or their pharmaceutically acceptable salts, which can be administered to inhibit the replication of these viruses and treat associated infections.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If no specific antiviral treatment is used for coronavirus, then the virus can replicate freely in host cells, but current treatments are lacking and ineffective
Solution Approach 1:
The patent modifies the molecular structure of existing antiviral compounds by changing chemical parameters (substituents, functional groups, molecular weight) to enhance their effectiveness against coronaviruses. Formula (I) compounds represent systematic structural modifications that optimize viral inhibition while maintaining safety profiles.
Solution Approach 2:
The invention creates composite molecular structures combining different functional moieties within a single compound molecule. These composite structures integrate multiple pharmacological activities to simultaneously inhibit viral replication and reduce harmful effects, achieving superior therapeutic efficacy.
2Adaptability or versatility
If broad-spectrum antiviral compounds are developed for multiple viruses, then treatment versatility improves, but compound specificity and efficacy for each virus may be compromised
Solution Approach 1:
The patent designs antiviral compounds with universal mechanisms that can inhibit multiple virus types (coronaviruses, picornaviruses, noroviruses) through conserved viral processes. The compounds target fundamental viral replication mechanisms that are preserved across different virus families, enabling single compounds to provide broad-spectrum coverage while maintaining high efficacy for each specific virus.
Data Source
AI summary
Provided herein are compounds of Formula (I), or pharmaceutically acceptable salts thereof, pharmaceutical compositions that include a compound described herein (including pharmaceutically acceptable salts of a compound described herein) and methods of synthesizing the same. Also provided herein are methods of treating diseases and/or conditions with a compound of Formula (I), or a pharmaceutically acceptable salt thereof.